Biogen
252 of 416 with a diagram, by size
Q1 FY26 Jan 1 – Mar 31, 2026
Revenue$2.48B
+2% year over year
Gross profit$1.82B
73% margin
Operating profit$0.46B
19% margin
Net profit$0.32B
13% margin
The numbers behind the diagram
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 2.48 | 100% | +2% |
| Cost of revenue | −0.66 | 27% | |
| Gross profit | 1.82 | 73% margin | −1pp |
| SG&A | −0.61 | 25% | +1pp |
| Other | −0.75 | 30% | +0pp |
| Operating profit | 0.46 | 19% margin | +0pp |
| Interest & other costs | −0.08 | ||
| Tax | −0.06 | ||
| Net profit | 0.32 | 13% margin | +3pp |
Financial health
The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.
The balance sheet, capital flow, debt schedule and capital structure open with a free account.
Quarter by quarter
So far we hold one set of results. Another one arrives with the next filing.
| Quarter | Period | Reported | Revenue | Year over year | Operating margin | Net profit | Net margin |
|---|---|---|---|---|---|---|---|
| Q1 FY26 Jan 1 – Mar 31, 2026 reported Apr 29, 2026 Operating margin 19% Net profit $0.32B | Jan 1 – Mar 31, 2026 | Apr 29, 2026 | $2.5B | +2% | 19% | $0.32B | 13% |
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest